---
title: "CONBA: Throat lozenges have obtained a drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241980565.md"
description: "According to the Zhitong Finance APP, CONBA announced that the company has received the Drug Registration Certificate for the throat lozenge approved and issued by the National Medical Products Administration (referred to as \"NMPA\"). The throat lozenge is an improvement on the already marketed throat mixture. The functions and indications of the throat lozenge include nourishing yin, clearing the throat, and detoxifying, used for treating acute pharyngitis classified as lung heat and yin deficiency syndrome in traditional Chinese medicine, characterized by throat pain (pain during swallowing), dry and burning throat, red tongue, thin coating, and thin pulse"
datetime: "2025-05-27T09:54:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241980565.md)
  - [en](https://longbridge.com/en/news/241980565.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241980565.md)
generator: "portal-rs"
---

# CONBA: Throat lozenges have obtained a drug registration certificate

According to the Zhitong Finance APP, CONBA (600572.SH) announced that the company has received the Drug Registration Certificate for the throat lozenge approved and issued by the National Medical Products Administration (referred to as "NMPA"). The throat lozenge is an improvement on the already marketed throat mixture. The functions and indications of the throat lozenge include nourishing yin, clearing the throat, and detoxifying, used for treating acute pharyngitis classified as lung heat and yin deficiency syndrome in traditional Chinese medicine, characterized by throat pain (pain during swallowing), dry and burning throat, red tongue, thin coating, and thin pulse

### Related Stocks

- [600572.CN](https://longbridge.com/en/quote/600572.CN.md)

## Related News & Research

- [Definium's LSD-based drug lowers anxiety in second successful late-stage study](https://longbridge.com/en/news/298906879.md)
- [MegaGen Announces Launch of BLUEDIAMOND ZYGOMA Implant at the 2026 NASM Symposium in Chicago](https://longbridge.com/en/news/299063618.md)
- [Teitur reports positive early data for Parkinson’s peptide TT‑P34](https://longbridge.com/en/news/298896579.md)
- [Orexo Announces FDA Acceptance Of Investigational New Drug Application](https://longbridge.com/en/news/298872290.md)
- [Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer](https://longbridge.com/en/news/298830338.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**